AOD9604 and GH fragment peptides in obesity pharmacotherapy

study083

10.1016/j.peptides.2006.06.017

Peptides

review article

Review of GH fragment pharmacology with focus on lipolytic activity and obesity treatment concepts.

GH fragments were presented as attempts to separate lipolysis from classical GH adverse effects.

aod-9604|hgh-frag-176-191

fat-loss|metabolism

metabolic-stack|recomposition-stack

hghfrag-vs-aod9604

published

‹ Bremelanotide clinical pharmacology and efficacy review

Growth hormone fragment 176-191 and adipose metabolism in obesity models ›